Gain-of-function mutations in Kir6.2 and SUR1 are associated with developmental delay, epilepsy, and neonatal diabetes (DEND) syndrome, which is accompanied by muscle flaccidity and motor impairment. This evidence concerns the gene KCNJ11 and epilepsy.